Pharos iBio Co., Ltd. (KOSDAQ: A388870)
Health Care · Biotechnology · KR
₩6,210.00
-3.12% today · +12.5% 1Y
Pharos iBio Co., Ltd. (KOSDAQ: A388870) operates in the Biotechnology industry within the Health Care sector. The company is valued at $60.30M.
Over the last twelve months the share price has gained 12.5%, trading between 3.71K and 12.12K.
Tweenvest scores Pharos iBio Co., Ltd. across four factors: quality 48/100, value 53/100. Its strongest factor is value.
A388870 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $60.30M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -733.12
- Dividend yield
- —
- Beta (5Y)
- -0.36
- 52-week high
- ₩12,120.00
- 52-week low
- ₩3,710.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.95M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Oncolytics Biotech Inc.NasdaqCM: ONCY | $63.51M | $0.50 | -10.57% |
| EyeGene Inc.KOSDAQ: A185490 | $63.26M | ₩1,951.00 | +4.33% |
| Nuo Therapeutics, Inc.OTCPK: AURX | $62.96M | $1.30 | +4.00% |
| OS Therapies IncorporatedNYSEAM: OSTX | $60.89M | $1.32 | -18.52% |
| Caribou Biosciences, Inc.NasdaqGS: CRBU | $60.04M | $0.56 | +2.87% |
| Hemogenyx Pharmaceuticals PlcLSE: HEMO | $59.69M | £6.58 | -10.48% |
| Zelluna ASAOB: ZLNA | $58.51M | Nkr18.50 | -5.85% |
| Adaptin Bio, Inc.OTCPK: APTN | $57.89M | $— | — |
Figures last refreshed Oct 18, 2026.